South Dakota’s House of Representatives approved a measure Thursday requiring the names of registered medical marijuana patients to be added to the state's prescription drug monitoring program.
Senate Bill 42, introduced by the chair of the Health and Human Services Department is now heading to Gov. Kristi Noem's desk. The measure provides several smaller amendments, but the only new section considers adding patient names to the drug monitoring program.
Lawmakers also approved Senate Bill 10 in a 48-21 vote sending it back to the Senate for a decision on a change proposed by a House Committee. Sponsored by state Senator Erin Tobin (R) SB 10 requires a notification of medical marijuana certification to be provided to a patient's primary or referring practitioner. The bill also requires that the patient's primary care provider or the referring practitioner should include any notification about medical marijuana certification in the patient's medical file.
Rep. Fred Deutsch (R) tried to include criminalization for failure to provide the notice, but that proposal was rejected in a 25-44 vote, reported Keloland Media Group.
Democratic Rep. Kadyn Wittman commented on Deutsch's amendments raising concerns about cases when a patient lies about having a primary provider. Rep. Roger DeGroot (R) looked at the list of health conditions that qualify a patient for a medical marijuana card and questioned how it is possible that those individuals don't have a medical provider. Deutcsh said it happens all the time.
Recent State Cannabis Milestones
The South Dakota Senate recently advanced a GOP-sponsored cannabis bill that would require parolees and probationers to get additional documents from doctors to become medical marijuana patients. The measure was approved in a 29-4 vote and is heading to a House committee.
The news came shortly after Gov. Noem (R) signed a bill into law that would allow employers in South Dakota to discipline workers who test positive for THC. This affects people in safety-sensitive roles, such as pilots, construction workers, healthcare professionals, teachers, nursing home employees and truck drivers, among others,
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world. Get your tickets now on bzcannabis.com – Prices will increase very soon!
Photo: Courtesy of shaneinsweden via Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.